CAT No: CP25574
CAS No:201853-23-8
Synonyms/Alias:201853-23-8;H-L-Lys-amc acoh;H-LYS-AMC ACOH;L-Lysine 7-amido-4-methylcoumarin acetate salt;L-Lysine 7-amido-4-methylcoumarin, acetate salt;acetic acid;(2S)-2,6-diamino-N-(4-methyl-2-oxochromen-7-yl)hexanamide;Hexanamide, 2,6-diamino-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-, (2S)-, monoacetate (9CI);(S)-2,6-Diamino-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide acetate;H-Lys-AMC⋅AcOH;DTXSID30647386;(2S)-2,6-diamino-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamide; acetic acid;MFCD00152123;AKOS025294847;CS-0357477;L-9300;(S)-2,6-Diamino-N-(4-methyl-2-oxo-2H-chromen-7-yl)hexanamideacetate;Acetic acid (2S)-2,6-diamino-N-(4-methyl-2-oxochromen-7-yl)hexanamide;Acetic acid--N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-lysinamide (1/1);(2S)-2,6-DIAMINO-N-(4-METHYL-2-OXOCHROMEN-7-YL)HEXANAMIDE; ACETIC ACID;
Chemical Name:L-Lysine 7-amido-4-methylcoumarin, acetate salt
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.